Chronic Kidney Disease
The Pharmacy Times® Chronic Kidney Disease resource center provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.
What can we help you find?
Todd Brothers, PharmD, BCCCP, BCPS, clinical assistant professor, University of Rhode Island, discusses what patients should know about medications that cause hyperkalemia. This video was filmed at the ASHP (American Society of Health-System Pharmacists) 54th Clinical Meeting & Exhibition in Las Vegas, Nevada.
New Health Management Application Provides Daily Health Management to Patients with Chronic Kidney Failure
Through the Automatic LifeStyle Advice platform, health service providers can integrate personal health trackers, allowing data to configure the optimal recommendation for diet, exercise, and daily health management.
Study findings presented at the American Society of Nephrology’s Kidney Week 2019 suggest a link between chronic use of proton pump inhibitors and progression of kidney function decline in chronic kidney disease.
Baclofen use, particularly at higher doses, may result in an increased risk of encephalopathy among patients with chronic kidney disease.
Todd Brothers, PharmD, BCCCP, BCPS clinical assistant professor, University of Rhode Island, discusses the role of pharmacists in assessing patients for hyperkalemia and in managing those with a chronic condition. This video was filmed at the ASHP (American Society of Health-System Pharmacists) 54th Clinical Meeting & Exhibition in Las Vegas, Nevada.
Patients with HIV who are diagnosed with chronic kidney disease have a higher burden of serious clinical events.
Jaclyn Harth, PharmD, clinical assistant professor, Fairleigh Dickinson School of Pharmacy, discusses the role of the health system pharmacist for patients with chronic hyperkalemia. This video was filmed at the ASHP (American Society of Health-System Pharmacists) 54th Clinical Meeting & Exhibition in Las Vegas, Nevada.
A recent study showed that effective lifestyle behavioral changes for patients with chronic kidney disease frequently involved education, goal setting, feedback, monitoring, and social support.
A retrospective cohort study was the second largest evaluation to date of sodium polystyrene sulphonate use and safety in patients with chronic kidney disease.
A study using genomics and proteomics identified new subtypes of clear cell renal cell carcinoma based on tumor microenvironment signatures.
More men than women initiate kidney replacement therapy despite a higher prevalence of chronic kidney disease seen in women.
A study published in the Clinical Journal of American Society of Nephrology found that a healthy dietary pattern may prevent chronic kidney disease (CKD) and albuminuria.